Coronavirus Disease 2019 (COVID-19) Vaccine Prioritization in Low- and Middle-Income Countries May Justifiably Depart From High-Income Countries’ Age Priorities

Eyal, Nir; Gheaus, Anca; Gosseries, Axel; Magalhães, Monica; Ngosso, Thierry; Steuwer, Bastian; Tangcharoensathien, Viroj; Trifan, Isa; Williams, Andrew

doi:10.1093/cid/ciac398

Cited by 4 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, priority-based vaccine allocation is considered a means to effectively distribute vaccine doses based on priority in recourse-constrained LMICs. For instance, age-based priority under the assumption that prioritizing the administration of the vaccine for elderly people may minimize COVID-19 associated deaths and hospitalizations [ 29 ]. Similar approaches are advocated by WHO [ 30 ].…”

Section: Discussionmentioning

confidence: 99%

Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups

Das,

Raha,

Adnan

et al. 2023

Heliyon

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups

Das,

Raha,

Adnan

et al. 2023

Heliyon

View full text Add to dashboard Cite

“…Since our study focuses on diabetic patients, it's conceivable that a higher proportion of individuals in the 41-60 age group had pre-existing diabetes, putting them at greater risk of mucormycosis. This is evident from studies that have explored the impact of COVID-19 vaccination on reducing infection rates in older populations, such as the research conducted by Eyal N et al [ 11 ] and Sezen YI et al [ 12 ]. Regarding gender disparities, our study identified a significant difference in the distribution of mucormycosis cases compared to the research conducted by Rahul Kulkarni et al [ 13 ].…”

Section: Discussionmentioning

confidence: 99%

A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis

Govindarajan,

et al. 2023

Cureus

View full text Add to dashboard Cite

Introduction Mucormycosis is a rare opportunistic fungal infection caused by fungi belonging to the Mucorales order and Mucoraceae family. It ranks as the third most prevalent angioinvasive fungal infection, following aspergillosis and candidiasis. This severe infection typically affects individuals with compromised immune systems, including those with hematological malignancies like leukemia and lymphoma, individuals who have undergone stem cell transplants, and people with diabetes mellitus. Individuals in good health are rarely affected, making immunocompromised individuals particularly vulnerable to this potentially fatal fungal disease. The aim of this study was to perform a comparative analysis of survivors versus non-survivors among diabetes patients admitted with mucormycosis. Methodology This was a descriptive observational study. A total of 338 patients were enrolled in the study. The study variables included demographics, COVID-19 infection, diabetes mellitus history, steroid use, use of oxygen support, and steam inhalation. Results Of the total 338 patients enrolled in the study, 253 (74.9%) were male and 85 (25.01%) were female. The number of survivors were 305 (90.2%) and non-survivors were 33(9.8%). The mean age of survivors was 52.50 ± 11.31 and non-survivors was 54.06 ± 8.54 years. Patients who underwent steam inhalation had a higher chance of survival compared to those who did not undergo steam inhalation and this association was statistically significant (p=0.01). Males showed a higher chance of survival (93.7%) as compared to females (80.0%). The associations between oxygen support, steroid use, and COVID-19 infection with the survival status were statistically non-significant. Conclusion There was a strong association between the history of steam inhalation and the outcome of mucormycosis among diabetes patients admitted with mucormycosis. Female patients demonstrated a higher fatality rate than males indicating a significant gender disparity observed in cases. Our findings may help to better identify and treat patients who are at higher risk for severe forms of mucormycosis.

show abstract

“…We acknowledge that our fairness framework takes a Western-centric perspective, particularly with respect to race, and is relevant mostly to countries containing urban areas with high diversity, as is more typical of the global West. The most effective strategy for each country, however, will not be the same (Eyal et al 2022). We therefore propose IM-I to counteract this bias; many non-Western countries may not have the same extent of racial diversity, but will still experience income disparities in their urban areas.…”

Section: Im With Equal Treatmentmentioning

confidence: 99%

Promoting Fair Vaccination Strategies through Influence Maximization: A Case Study on COVID-19 Spread

Neophytou,

Taik,

Farnadi

2024

AAAI

View full text Add to dashboard Cite

The aftermath of the Covid-19 pandemic saw more severe outcomes for racial minority groups and economically-deprived communities. Such disparities can be explained by several factors, including unequal access to healthcare, as well as the inability of low income groups to reduce their mobility due to work or social obligations. Moreover, senior citizens were found to be more susceptible to severe symptoms, largely due to age-related health reasons. Adapting vaccine distribution strategies to consider a range of demographics is therefore essential to address these disparities. In this study, we propose a novel approach that utilizes influence maximization (IM) on mobility networks to develop vaccination strategies which incorporate demographic fairness. By considering factors such as race, social status, age, and associated risk factors, we aim to optimize vaccine distribution to achieve various fairness definitions for one or more protected attributes at a time. Through extensive experiments conducted on Covid-19 spread in three major metropolitan areas across the United States, we demonstrate the effectiveness of our proposed approach in reducing disease transmission and promoting fairness in vaccination distribution.

show abstract

Coronavirus Disease 2019 (COVID-19) Vaccine Prioritization in Low- and Middle-Income Countries May Justifiably Depart From High-Income Countries’ Age Priorities

Cited by 4 publications

References 22 publications

Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups

Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups

A Comparative Study on Survivors Versus Non-Survivors Among Diabetic Patients Having Mucormycosis

Promoting Fair Vaccination Strategies through Influence Maximization: A Case Study on COVID-19 Spread

Contact Info

Product

Resources

About